Macquarie Group LTD Igm Biosciences, Inc. Transaction History

Macquarie Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $8,928 - $15,638	-579 Closed	0 $13,000
Q2 2021 Aug 13, 2021	BUY	$57.98 - $96.6 $25,453 - $42,407	439 Added 313.57%	579 $48,000
Q1 2021 May 14, 2021	SELL	$71.56 - $121.23 $4,722 - $8,001	-66 Reduced 32.04%	140 $11,000
Q2 2020 Aug 11, 2020	BUY	$51.3 - $75.21 $10,567 - $15,493	206 New	206 $15,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $492M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.